COMMUNIQUÉS West-GlobeNewswire
-
TOMI Environmental Solutions, Inc. Expands Presence in the United Kingdom With New Distribution Agreement
19/12/2017 - 15:30 -
Asklepion Pharmaceuticals Announces Special Protocol Assessment (SPA) Agreement with FDA for Phase 3 Program of Intravenous Citrulline
19/12/2017 - 15:00 -
Dr. Axe Launches New Keto Diet and Fitness Plan for 2018
19/12/2017 - 15:00 -
Chembio Diagnostics and AstraZeneca Enter a Collaboration to Develop Point-of-Care Diagnostic Test
19/12/2017 - 14:50 -
Yield10 Bioscience Announces Pricing of $12.6 Million Public Offering
19/12/2017 - 14:43 -
Teladoc to Participate in Upcoming Investor Conference
19/12/2017 - 14:35 -
Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
19/12/2017 - 14:31 -
Hemispherx Highlights Year-To-Date Progress, Outlines Key Objectives
19/12/2017 - 14:30 -
EHNAC Partners With OmniSystems, Inc. to Extend Reach of Accreditation Programs Internationally
19/12/2017 - 14:30 -
Clinical Genomics Pathology Inc. Receives Accreditation from College of American Pathologists (CAP) for Liquid Biopsy Lab
19/12/2017 - 14:30 -
EyeGate Awarded New U.S. Patent for Iontophoretic Delivery of Corticosteroids to the Eye
19/12/2017 - 14:30 -
New “Test and Treatment” Allergy Program Enables All Physicians To Provide Convenient And Effective Allergy Care
19/12/2017 - 14:17 -
Minerva Neurosciences Screens First Patient in Phase 3 Trial Of MIN-101 to Treat Negative Symptoms in Schizophrenia
19/12/2017 - 14:00 -
Opiant Pharmaceuticals to Ring The Nasdaq Opening Bell on December 20, 2017
19/12/2017 - 14:00 -
Tyme to Present Efficacy Data on SM-88 in Pancreatic Cancer at 2018 ASCO Gastrointestinal Cancers Symposium
19/12/2017 - 14:00 -
VBI Vaccines Announces Initiation of Phase 3 Clinical Program for Sci-B-Vac® Hepatitis B Vaccine
19/12/2017 - 14:00 -
Ovid Therapeutics Announces OV101 Granted Fast Track Designation by U.S. FDA for Treatment of Angelman Syndrome
19/12/2017 - 14:00 -
Apixio’s AI-Based Technology Delivers More Accurate Risk Adjustment to Meet Industry Demand for Compliant Solutions
19/12/2017 - 14:00 -
INSYS Therapeutics Initiates Phase 2 Clinical Trial of Cannabidiol (CBD) Oral Solution for Treatment of Refractory Childhood Absence Epilepsy in Pediatric Patients
19/12/2017 - 14:00
Pages